Product Information
PACERONE 100 MG TABLET is a brand (anda) product labeled by Upsher-Smith Laboratories LLC, priced at $0.7762 per EA under NDC 00245014401. Its NADAC has been published 588 times since Nov 28, 2013.
FDA first approved this application on Apr 30, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245014401
Classification
Brand (ANDA)
Dosage Form
TABLET
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
AMIODARONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075135FDA Approved
4/30/1998
TE Code
AB
On Market Since
11/15/2010
Pharmacological Classes
Price Statistics
The NADAC for PACERONE 100 MG TABLET has been published 588 times since Nov 28, 2013, and over the history we have for it it has declined 69.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7762 per EA |
|---|---|
| All-time high | $3.7597 (Aug 13, 2014) |
| All-time low | $0.7699 (Mar 19, 2025) |
| 52-week high | $0.8311 |
| 52-week low | $0.7762 |
| Median price | $2.4276 |
| Average price | $2.0647 |
| Largest weekly change | -55.6% (Oct 13, 2021) |
| Weeks tracked | 588 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amiodarone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiarrhythmic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PACERONE 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PACERONE 100 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.7762 per EA (NDC 00245014401), effective Sep 30, 2026.
How has the price of PACERONE 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for PACERONE 100 MG TABLET has declined 69.4%. It has been tracked across 588 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PACERONE 100 MG TABLET?
Since Nov 28, 2013, the NADAC for PACERONE 100 MG TABLET has ranged from a low of $0.7699 (Mar 19, 2025) to a high of $3.7597 (Aug 13, 2014), with a median of $2.4276 per EA.
Are there cheaper alternatives to PACERONE 100 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMIODARONE HCL 100 MG TABLET, is $0.3758 per EA — about 52% below PACERONE 100 MG TABLET.
Who manufactures PACERONE 100 MG TABLET?
PACERONE 100 MG TABLET (NDC 00245014401) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand (anda) product.